ALS Progression Rate Before Diagnosis Fails to Predict Individual Disease Course, Landmark Study Finds
A population-based study of nearly 4,000 ALS patients in Italy shows that the widely used pre-diagnostic ALSFRS-R slope predicts group-level ...
A population-based study of nearly 4,000 ALS patients in Italy shows that the widely used pre-diagnostic ALSFRS-R slope predicts group-level ...
An analysis of nearly half a million clinical trials and real-world data from over 91,000 patients reveals that immune-related side ...
Around 10,000 experts from 138 countries will gather in Vienna from October 17 to 21, 2026, for EANM'26 as theranostics, ...
Post hoc analyses of the SIMPLIFY-1 and MOMENTUM phase 3 trials show that myelofibrosis patients treated with momelotinib who achieve ...
A new framework published in Annals of Clinical and Translational Neurology proposes integrating community engagement and implementation science across the ...
New USC Schaeffer Center modeling projects that starting Alzheimer's treatment with donanemab two years earlier raises lifetime societal value by ...
A new Nature Reviews Clinical Oncology review synthesizes epidemiological, trial and mechanistic evidence to argue that structured exercise is emerging ...
A new review details how chimeric antigen receptor-engineered macrophages are overcoming the barriers that stalled CAR-T therapy in solid tumors, ...
A new systematic review finds that about one in five adults with diffuse large B-cell lymphoma develops febrile neutropenia during ...
A new Nature Reviews Neurology roadmap charts how blood-based molecular biomarkers of brain injury, metabolism, inflammation and gut dysbiosis could ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine